SCHEMBL1034820

SCHEMBL1034820

Fc1ccc(-c2ccnc(NC3CCCCC3)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.57
MAPK13 O15264 1/20 0.57
MAPK12 P53778 1/20 0.57
MAPK11 Q15759 1/20 0.57
MAPK14 Q16539 1/20 0.57
IKBKB O14920 3/20 0.56
CDK1 P06493 4/20 0.53
CCNB1 P14635 4/20 0.53
CCNA2 P20248 3/20 0.53
CCND1 P24385 3/20 0.53
CDK2 P24941 3/20 0.53
CCNA1 P78396 3/20 0.53
MAPK8 P45983 2/20 0.53
MAPK9 P45984 2/20 0.53
MAPK10 P53779 2/20 0.53
CTSK P43235 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
CDC7 O00311 1/20 0.51
PLK4 O00444 1/20 0.51
JAK2 O60674 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21621306 0.93 CDK4 (0.63) CDK4MAPK13MAPK12MAPK11MAPK14
SCHEMBL1031885 0.87 CDK1 (0.52) CDK4MAPK13MAPK12MAPK11MAPK14
SCHEMBL1029919 0.86 IKBKB (0.57) CDK4MAPK11MAPK14IKBKBCDK1
SCHEMBL1032138 0.86 IKBKB (0.76) CDK4IKBKBCDK1CCNB1CCNA2
SCHEMBL1033987 0.86 IKBKB (0.56) CDK4MAPK13MAPK12MAPK14IKBKB
SCHEMBL1028968 0.84 MAP4K4 (0.55) CDK4IKBKBCDK1CCNB1CCNA2
SCHEMBL5819159 0.83 MAPK13 (0.48) CDK4MAPK13MAPK12MAPK11MAPK14
SCHEMBL1033533 0.83 CDK1 (0.51) CDK4MAPK13MAPK12MAPK11MAPK14
SCHEMBL1034547 0.82 EIF2AK2 (0.58) CDK4IKBKBCDK1CCNB1CCNA2
SCHEMBL1034791 0.82 MAPK1 (0.54) CDK4IKBKBCDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed